Cosmos Health is a small, Greece-based healthcare company that operates primarily as a pharmaceutical wholesaler, with a secondary focus on proprietary branded products and an early-stage R&D pipeline. The core business — which drives roughly 97% of revenues — is full-line pharmaceutical distribution in Greece, where the company buys prescription drugs, OTC medicines, medical devices, and nutraceuticals from manufacturers and resells them to pharmacies, hospitals, and other distributors, earning a spread on each transaction. Cosmos Health uses automated warehouse technology to manage inventory and fulfillment. Alongside distribution, the company develops and sells its own branded nutraceutical lines (Sky Premium Life and Mediterranation, covering ~165 SKUs), proprietary biocides and antiseptic soaps (C-Sept and C-Scrub), and a portfolio of 10 generic pharmaceuticals covering conditions including cholesterol, diabetes, and Alzheimer's. These proprietary products carry higher margins than third-party distribution, and growing them as a share of revenue is a stated priority. Cosmos Health also operates a GMP-certified contract manufacturing subsidiary, an AI-powered drug repurposing platform (Cloudscreen), an obesity drug candidate (CCX0722) targeting a 2026 launch, early-stage oncology programs, and a U.S.-facing telemedicine platform (ZipDoctor). All of these non-distribution businesses are either nascent or pre-revenue, and Cosmos Health's near-term financial results will continue to be driven almost entirely by its Greek wholesaling operations.